Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Women at Risk for Pregnancy (MK-8342B-061)

NCT02524288 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1941

Enrollment

INDUSTRY

Sponsor class

Stopped This study was terminated by the Sponsor due to a business decision to discontinue product development for reasons unrelated to safety or efficacy outcomes.

Conditions

Contraception

Interventions

DRUG: ENG-E2 125 μg/300 μg vaginal ring

Sponsor

Organon and Co